Friuli Venezia Giulia

• Main Authors: Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi
• Format: Article
• Language: English
• Published: SEEd Medical Publishers 2008-09-01
• Series: Farmeconomia: Health Economics and Therapeutic Pathways
• Subjects: friuli venezia giulia; hpv vaccination; economic & clinical impact
• Online Access: https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1005
• ISSN: 2240-256X

In Friuli Venezia Giulia region 75,1% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 15 cases of cervicocarcinoma and 6 related deaths and thus results to be cost-effective (27.766 €/QALY). When the vaccination programme is extended to 16-year-old girls a further 14 cancer cases and 6 deaths could be prevented, with a very similar cost-effectiveness ratio. In Friuli Venezia Giulia region, the net cost for woman vaccinated is 167 € for the single cohort and 169 € for the multiple cohort.